Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.1202
Recommendation HOLD
P/E 33.39
ROE 13.25 %
Capitalization 3,310,852,000 $
Dividend Yield 0.00 %
P/S 4.39
AII Position 465
P/E Position 447
ROE Position 309
Capitalization Position 647
Dividend Yield Position 629
Sales 753,800,000 $
10-Year Average Earnings 99,152,600 $
Shares Outstanding 72,400,000
Equity 748,100,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2016 6 753,800,000.00 $
2015 6 723,100,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2016 6 125,300,000.00 $
2015 6 80,200,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $
2008 6 47,845,000.00 $
2007 6 -34,962,000.00 $

Equity:

YEAR MONTH AMOUNT
2016 6 748,100,000.00 $
2015 6 662,100,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
620 87,737 MYRX MYREXIS INC 171,102 212,920 27,673 MYGN MYRIAD GENETICS 2,889,711 2,829,144 719,834 NABI NABI BIOPHARMA...
Feb 7, 2005
Online Extra: Healthy Investment?
5.46 Prostate Cancer VIOLTS (FTPCSX) Myriad Genetics (MYGN) 10.07 Medarex (MEDX) ...
Dec 30, 2005
S&P's Top-Shelf Selections
of $135 billion for Procter & Gamble (PG ) to a low of $700 million for Myriad Genetics (MYGN ). By contrast, the median market capitalization of the S&P 500 index is about $10.3 billion...
Dec 14, 2006
S&P Ups Oracle to Strong Buy
reflecting a multiple reduction due to the aforementioned sales risks. Myriad Genetics (MYGN): Cuts to 3 STARS (hold) from 4 STARS (buy) Analyst: Paul Starsia Our downgrade comes...
Aug 26, 2003
CS First Boston Lowers Myriad Genetics to 'Neutral'
Credit Suisse First Boston downgraded Myriad Genetics (MYGN ) to neutral from outperform. Analyst Mark Augustine says...
Nov 17, 2003
Raising Forecast for Children's Place
estimate: .55 Rationale: See stronger operating income Company: Myriad Genetics (MYGN ) Year ending: Jun-2004 Prior estimate: -1.11 New estimate: -1.34 ...
May 22, 2001
Reaping the Bush Dividend
one called Human Genome Sciences (HGSI ), and there's another one called Myriad Genetics (MYGN ). I'm not necessarily recommending those firms as the best ones to look at, but I'm saying...
May 1, 2012
U.S. Companies Reporting Higher Quarterly EPS, May 1
Q12 % CHG Q/E ======================================================================== MYGN# MYRIAD GENETICS 0.34 0.31 9.7 0.32 6.3 Mar GLAD# GLADSTONE CAP CO ...
Aug 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Aug. 9
2.84 10.66 HPT HOSPITALITY PROP 0.89 0.81 9.9 0.86 3.5 2.45 12.86 MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 1.07 5.97 TNGN# TENGION INC...
Aug 9, 2011
U.S. Companies Reporting Earnings on Aug. 9
99.5 0.08 NM Jun MRVC# MRV COMM 0.01 na na 0.01 0.0 Jun MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 Jun TICKER ...


Google News for MYRIAD GENETICS:

Yahoo Finance - 1 day ago
Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings?
Last quarter, the company posted a positive earnings surprise of 8.33%. However, Myriad Genetics missed the Zacks Consensus Estimate in ...
HuronReport - 14 hours ago
WestJet Airlines Ltd. (WJA) EPS Estimated At $0.52, Myriad ...
Deutsche Bank initiated Myriad Genetics, Inc. (NASDAQ:MYGN) on Thursday, January 7 with “Buy” rating. Morgan Stanley maintained it with ...
Sports Perspectives
Myriad Genetics (MYGN) Says Study Finds Wide Gap in Quality of ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that new data ...
Transcript Daily
Myriad Genetics (MYGN) Earning Somewhat Favorable News ...
Myriad Genetics logo News coverage about Myriad Genetics (NASDAQ:MYGN) has trended somewhat positive on Saturday, Alpha One ...
The Cerbat Gem
Option Market Alert: Myriad Genetics Inc Implied Price Swing Hits An ...
No Risk Alert Here: Before we dive into any analysis we simply note that Myriad Genetics Inc (NASDAQ:MYGN) risk is neither elevated nor ...
StreetInsider.com - 17 Apr 2017
How Does Myriad Genetics, Inc. (MYGN) Stack Up Right Now?
Myriad Genetics, Inc. (MYGN) is an interesting player in the Services space, with a focus on Research Services. The stock has been active on ...
Markets Daily
What are Analyst's Indicators for Cardinal Health (CAH), Myriad ...
On 03/30/2017 close, Myriad Genetics, Inc. (NASDAQ:MYGN) plummeted -0.42% to $19.12. The stock currently has a Market Cap of $1.30B.
The Cerbat Gem
Stock Returns: Emergent BioSolutions Inc (NYSE:EBS) versus ...
This is a snapshot to compare the stock returns for Emergent BioSolutions Inc (NYSE:EBS) versus Myriad Genetics Inc (NASDAQ:MYGN) .
Sports Perspectives
Myriad Genetics (MYGN) Given Daily Coverage Optimism Score of ...
Myriad Genetics logo News stories about Myriad Genetics (NASDAQ:MYGN) have trended somewhat positive recently, according to Alpha One ...
Sports Perspectives - 3 days ago
Stock Returns: Myriad Genetics Inc (NASDAQ:MYGN) versus ...
This is a snapshot to compare the stock returns for Myriad Genetics Inc (NASDAQ:MYGN) versus Repligen Corporation (NASDAQ:RGEN) .


Back